Researchers discovered that new medications used in the treatment of obesity, such as GLP-1 agonists, are associated with a significant reduction in asthma attacks. The study revealed that people with asthma or chronic obstructive pulmonary disease who received this new treatment had fewer acute respiratory crises. The results suggest that these medications may have benefits that go beyond weight loss, positively affecting the respiratory airways. The research opens new perspectives for the treatment of chronic respiratory diseases.
Science
Медицина
New obesity drugs linked to reduction in asthma attacks
Now8 September 2026 at 11:36
Related articles




